This is in line with a previous study by Jiskoot et al. [16] that demonstrated significant decline on the RAVLT recall test in the presymptomatic stage of MAPT mutation carriers, with a further decline in participants that converted to symptomatic FTD during follow-up. Here, MAPT is linked to frontotemporal dementia.